Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Collegium Pharmaceutical Inc

COLL
29,22
-0,41 (-1,38%)
Ultimo aggiornamento: 18:55:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202521:16EDGAR2Form 144 - Report of proposed sale of securities
11/3/202521:08EDGAR2Form 144 - Report of proposed sale of securities
10/3/202523:57GLOBECollegium Announces Poster Presentations at the 2025..
10/3/202521:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/3/202521:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202522:21EDGAR2Form 144 - Report of proposed sale of securities
07/3/202522:13EDGAR2Form 144 - Report of proposed sale of securities
07/3/202500:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202522:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202516:42EDGAR2Form 144 - Report of proposed sale of securities
05/3/202521:03EDGAR2Form 144 - Report of proposed sale of securities
04/3/202522:16EDGAR2Form 144 - Report of proposed sale of securities
04/3/202514:00GLOBECollegium to Participate in Upcoming Investor Conferences
27/2/202522:01EDGAR2Form 8-K - Current report
27/2/202522:01GLOBECollegium Reports Record Fourth Quarter and Full-Year 2024..
13/2/202522:01EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
13/2/202514:00GLOBECollegium to Report Fourth Quarter and Full-Year 2024..
12/2/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202522:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202523:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/2/202514:05EDGAR2Form 8-K - Current report
05/2/202514:00GLOBECollegium Appoints Nancy S. Lurker to its Board of Directors
14/1/202522:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202522:14EDGAR2Form 144 - Report of proposed sale of securities
08/1/202514:05EDGAR2Form 8-K - Current report
08/1/202514:00GLOBECollegium Provides 2025 Financial Guidance and Business..
14/11/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202414:00GLOBECollegium to Participate in Upcoming Investor Conferences
07/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:02GLOBECollegium Reports Record Third Quarter 2024 Financial..
07/11/202422:01EDGAR2Form 8-K - Current report
07/11/202422:01GLOBECollegium Appoints Vikram Karnani as Chief Executive Officer
24/10/202414:00GLOBECollegium to Report Third Quarter 2024 Financial Results on..
17/9/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202416:39EDGAR2Form 144 - Report of proposed sale of securities
13/9/202416:06EDGAR2Form 144 - Report of proposed sale of securities
06/9/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202417:53EDGAR2Form 144 - Report of proposed sale of securities
05/9/202422:47EDGAR2Form 144 - Report of proposed sale of securities
04/9/202414:03EDGAR2Form 8-K - Current report
30/8/202414:00GLOBECollegium to Participate in H.C. Wainwright 26th Annual..
28/8/202414:00GLOBECollegium Announces Eight Poster Presentations at PAINWeek..
15/8/202422:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202420:41EDGAR2Form 144 - Report of proposed sale of securities
09/8/202422:34EDGAR2Form 144 - Report of proposed sale of securities
08/8/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:01EDGAR2Form 8-K - Current report
Apertura: 29,59 Min: 28,9393 Max: 29,91
Chiusura: 29,63

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network